AstraZeneca’s China Trip Yields CSPC Obesity Deal Worth $1.2B Upfront - BioSpace

2026-01-30 - 13:35

AstraZeneca’s China Trip Yields CSPC Obesity Deal Worth $1.2B Upfront BioSpace

Share this post:

← Back to feed